Kirjaudu sisään Inderes Free -tilillesi nähdäksesi kaikki sivun maksuton sisältö.
BioGaia
104
SEK
−1,61 %
Alle 1K seuraajaa
BIOG B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Yleiskuva
Omistajat
Sijoittajakonsensus
−1,61%
+3,28%
−18,37%
−7,06%
0%
−21,69%
+4%
+7,33%
+1 364,11%
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.
Lue lisääMarkkina-arvo
10,52 mrd. SEK
Vaihto
10,89 milj. SEK
Liikevaihto
EBIT %
P/E -luku
Osinkotuotto %
Pörssikalenteri
18.7.
2025
Osavuosikatsaus Q2'25
22.10.
2025
Osavuosikatsaus Q3'25
Kaikki
Webcastit
Tiedotteet
NäytäKaikki sisältötyypit

BioGaia, Audiocast with teleconference, Q1'25
BioGaia AB: Interim Management Statement January - March 2025
Liity Inderesin yhteisöön
Älä jää mistään paitsi – luo käyttäjätunnus ja ota kaikki hyödyt irti Inderesin palvelusta.
FREE-tili
Pörssin suosituin aamukatsaus
Analyytikon kommentit ja suositukset
Osakevertailu
PREMIUM-tili
Kaikki yhtiöraportit ja sisällöt
Premium-työkalut (mm. sisäpiirin kaupat ja screeneri)
Mallisalkku
Notice to attend the Annual General Meeting of BioGaia AB (publ)
BioGaia Annual and Sustainability Report 2024 published
Transition in BioGaia: Anatom Holding, a Switzerland-based long-term investment firm, becomes anchor shareholder

BioGaia, Audiocast with teleconference, Q4'24
BioGaia AB: Year-end report January - December 2024
BioGaia's results for the fourth quarter to exceed market expectations
BioGaia launches a new probiotic supplement, BioGaia® Gastrus® PURE ACTION, designed for people with sensitive digestive systems

BioGaia, Audiocast with teleconference, Q3'24
BioGaia AB: Interim Management Statement January - September 2024
BioGaia's preliminary results for the third quarter did not reach market expectations
Change in the number of shares and votes in BioGaia AB (publ)
Change in the number of shares and votes in BioGaia AB (publ)
Change in the number of shares and votes in BioGaia AB (publ)

BioGaia, Audiocast with teleconference, Q2'24
BioGaia AB: Interim Management Statement January - June 2024
Annual General Meeting of BioGaia
